PHARMACOLOGY ANALYTIC

共享资源描述 自1985年药理学分析核心成立以来，核心的主要使命一直是 为了能够在临床试验和临床前研究的设计中纳入关键的药理学终点， 并通过提供低成本、最先进的服务，激发新的假设和研究领域。的 核心的目的是：1）为用户提供药理学试验设计，分析方法， 开发、定量测定、药代动力学数据分析和数据解释， 专业和经验丰富的设施; 2）提供真实的时间服务; 3）最大限度地减少癌症中心的成本和工作量 研究者; 4）避免重复设备、技术工作以及分析和药代动力学分析 通过灵活分配人员和设备，为癌症中心提供专业知识。核心资源 提供最先进的设备，设施和药理学试验设计，分析定量， 在Bunting-Blaustein癌症中心一楼约1000平方英尺的空间进行数据分析 研究大楼。核心区的位置在面积和位置上都足以满足巨蟹座的需要 研究药物代谢和处置以及药效学的中心研究者， 抗癌药物遗传学。

DESCRIPTION OF SHARED RESOURCE Since the founding of the Pharmacology Analytical Core in 1985, the primary mission of the Core has been to enable the inclusion of critical pharmacological endpoints in the design of clinical trials and preclinical studies, and stimulate new hypotheses and areas of investigation by providing low-cost, state-of-the-art services. The purpose of the Core is to: 1) provide users with expertise in pharmacological trial design, analytical method development, quantitative assays, pharmacokinetic data analysis, and data interpretation in a centralized, dedicated and experienced facility; 2) provide services in real time; 3) minimize cost and effort for Cancer Center investigators; 4) prevent duplication of equipment, technical effort and analytical and pharmacokinetic analysis expertise for the Cancer Center by providing flexible assignment of personnel and equipment. The Core resource provides state-of-the-art equipment, facilities, and expertise in pharmacological trial design, analytical quantitation, and data analysis in approximately 1000 square footage of space on the first floor of the Bunting-Blaustein Cancer Research Building. The location of the Core is adequate both in size and location to meet the needs of the Cancer Center investigators to investigate drug metabolism and disposition and the pharmacodynamics and pharmacogenetics of anticancer agents.